AMYLIN PHARMACEUTICALS INC Contracts & Agreements

FIRST SUPPLEMENTAL INDENTURE (Filed With SEC on August 13, 2012)

AMENDMENT TO COMMERCIAL SUPPLY AGREEMENT (Filed With SEC on August 3, 2012)

SIXTH AMENDMENT TO EXENATIDE MANUFACTURING AGREEMENT (Filed With SEC on August 3, 2012)

AGREEMENT AND PLAN OF MERGER BY AND AMONG BRISTOL-MYERS SQUIBB COMPANY, B&R ACQUISITION COMPANY AND AMYLIN PHARMACEUTICALS, INC. DATED AS OF JUNE 29, 2012 TABLE OF CONTENTS (Filed With SEC on July 3, 2012)

ASSUMPTION AGREEMENT (Filed With SEC on July 3, 2012)

MASTER SERVICE AGREEMENT (Filed With SEC on May 7, 2012)

13,000,000 Amylin Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on March 9, 2012)

AMYLIN PHARMACEUTICALS, INC. SECURED PROMISSORY NOTE (Filed With SEC on February 22, 2012)

SECURITY AGREEMENT among AMYLINPHARMACEUTICALS, INC., AMYLIN OHIO LLC, EACH OF THE OTHER GRANTORS PARTY HERETO and ELI LILLY AND COMPANY November 7, 2011 TABLE OF CONTENTS (Filed With SEC on February 22, 2012)

SUBSIDIARY GUARANTEE AGREEMENT (Filed With SEC on February 22, 2012)

AMENDED AND RESTATED LOAN AGREEMENT BETWEEN AMYLIN PHARMACEUTICALS, INC. AND ELI LILLY AND COMPANY AMENDED AND RESTATED LOAN AGREEMENT (Filed With SEC on February 22, 2012)

AMENDED AND RESTATED PROMISSORY NOTE (Filed With SEC on February 22, 2012)

Summary Description of Named Executive Officer Oral At-WillEmployment Agreement (Filed With SEC on February 22, 2012)

C O N F I D E N T I A L EXENATIDE SUPPLY AGREEMENT (Filed With SEC on February 22, 2012)

SUPPLY AGREEMENT BETWEEN ALKERMES, INC. AND AMYLIN OHIO LLC SUPPLY AGREEMENT (Filed With SEC on February 22, 2012)

THIRD AMENDMENT TO COMMERCIAL SUPPLY AGREEMENT BETWEEN AMYLIN PHARMACEUTICALS, INC. AND WOCKHARDT UK (HOLDINGS) LTD. (Filed With SEC on February 22, 2012)

SECOND AMENDMENT TO THE COMMERCIAL SUPPLY AGREEMENT (Filed With SEC on February 22, 2012)

SETTLEMENT AND TERMINATION AGREEMENT by and between AMYLIN PHARMACEUTICALS, INC. and ELI LILLYAND COMPANY November 7, 2011 TABLE OF CONTENTS (Filed With SEC on February 22, 2012)

AMENDED AND RESTATED EXENATIDE ONCE WEEKLY SUPPLY AGREEMENT (Filed With SEC on February 22, 2012)

AMENDED AND RESTATED DEVICE AND FINISHED EQW PRODUCT MANUFACTURING AGREEMENT (Filed With SEC on February 22, 2012)

AMENDMENT TO DEVICE DEVELOPMENT AND MANUFACTURING AGREEMENT (Filed With SEC on October 28, 2011)

AMYLIN PHARMACEUTICALS, INC. 2003NON-EMPLOYEE DIRECTORS EQUITY INCENTIVE PLAN ADOPTED APRIL 2, 2003 APPROVED BY STOCKHOLDERS MAY 14, 2003 ORIGINAL EFFECTIVE DATE: APRIL 2, 2003... (Filed With SEC on May 5, 2011)

AMYLIN PHARMACEUTICALS, INC. 2003 NON-EMPLOYEE DIRECTORS EQUITY INCENTIVEPLAN RESTRICTED STOCK UNIT AWARDAGREEMENT (Filed With SEC on May 5, 2011)

AMYLIN PHARMACEUTICALS, INC. 2009 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT (Filed With SEC on May 5, 2011)

[Amylin Letterhead] (Filed With SEC on May 5, 2011)

Summary Description of Named Executive Officer Oral At-Will Employment Agreement (Filed With SEC on February 25, 2011)

________________________________________________ Amylin Pharmaceuticals, Inc. 2001 Non-Qualified Deferred Compensation Plan (Filed With SEC on February 25, 2011)

AMYLIN PHARMACEUTICALS, INC. 2009 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT (Filed With SEC on February 25, 2011)

SECOND AMENDMENT TO MASTER SERVICES AGREEMENT BETWEEN AMYLIN PHARMACEUTICALS, INC. AND WOCKHARDT UK (HOLDINGS) LTD. (Filed With SEC on February 25, 2011)

AMENDMENT TO COMMERCIAL SUPPLY AGREEMENT FOR EXENATIDE (Filed With SEC on November 8, 2010)

THIRD Amendment to Commercial Supply Agreement for Exenatide (Filed With SEC on November 8, 2010)

[on Amylin Letterhead] (Filed With SEC on August 5, 2010)

AMYLINPHARMACEUTICALS, INC. 2009 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AWARDAGREEMENT (Filed With SEC on May 6, 2010)

[Amylin Letterhead] (Filed With SEC on May 6, 2010)

AMYLINPHARMACEUTICALS, INC. 2003 NON-EMPLOYEE DIRECTORS STOCK OPTION PLAN STOCK OPTION AGREEMENT (NONSTATUTORY STOCK OPTION) (Filed With SEC on February 26, 2010)

SummaryDescription of Named Executive Officer Oral At-Will Employment Agreement (Filed With SEC on February 26, 2010)

LICENSE,DEVELOPMENT AND COMMERCIALIZATION AGREEMENT BY AND BETWEEN AMYLIN PHARMACEUTICALS,INC. AND TAKEDA PHARMACEUTICALCOMPANY LIMITED DATED: OCTOBER 30, 2009 (Filed With SEC on February 26, 2010)

[AMYLIN LETTERHEAD] (Filed With SEC on February 26, 2010)

THIRDAMENDMENT (Filed With SEC on February 26, 2010)

Re: Collaboration Agreement between Eli Lilly and Company (Lilly) and Amylin Pharmaceuticals, Inc. (Amylin), dated September 19, 2002, as amended to date (the Collaboration... (Filed With SEC on August 7, 2009)

COST ALLOCATION AGREEMENT (Filed With SEC on August 7, 2009)

SECONDAMENDMENT, CONSENT AND WAIVER (Filed With SEC on August 7, 2009)

EXENATIDEONCE WEEKLY PEN SUPPLY AGREEMENT (Filed With SEC on August 7, 2009)

AMYLINPHARMACEUTICALS, INC. 2009EQUITY INCENTIVE PLAN (Filed With SEC on June 10, 2009)

AMYLINPHARMACEUTICALS, INC. 2009 EQUITYINCENTIVE PLAN STOCK OPTIONAGREEMENT (INCENTIVESTOCK OPTION OR NONSTATUTORY STOCK OPTION) (Filed With SEC on June 10, 2009)

AMYLINPHARMACEUTICALS, INC. 2001EMPLOYEE STOCK PURCHASE PLAN, AS AMENDED (Filed With SEC on June 10, 2009)

AMYLIN PHARMACEUTICALS, INC. 2003 NON-EMPLOYEE DIRECTORSSTOCK OPTION PLAN ADOPTED APRIL 2, 2003 APPROVED BY STOCKHOLDERS MAY 14,2003 EFFECTIVE DATE: APRIL 2, 2003 LAST AMENDED:... (Filed With SEC on May 11, 2009)

AMYLINPHARMACEUTICALS, INC. 2003 NON-EMPLOYEE DIRECTORS STOCK OPTION PLAN STOCK OPTIONAGREEMENT (NONSTATUTORY STOCK OPTION) (Filed With SEC on May 11, 2009)

EXHIBIT A (Filed With SEC on May 11, 2009)

AMYLIN PHARMACEUTICALS, INC. AMENDED AND RESTATED OFFICER CHANGE IN CONTROL SEVERANCE BENEFIT PLAN (Filed With SEC on February 27, 2009)

SummaryDescription of Named Executive Officer Oral At-Will Employment Agreement (Filed With SEC on February 27, 2009)

EXENATIDEONCE WEEKLY SUPPLY AGREEMENT (Filed With SEC on February 27, 2009)

LOANAGREEMENT BETWEEN AMYLINPHARMACEUTICALS, INC. AND ELILILLY AND COMPANY (Filed With SEC on February 27, 2009)

FIRSTAMENDMENT (Filed With SEC on February 27, 2009)

AMENDMENT TO THE COMMERCIAL SUPPLY AGREEMENT (Filed With SEC on February 27, 2009)

AMENDMENT TO THE AMENDED AND RESTATED COMMERCIAL SUPPLY AGREEMENT (Filed With SEC on February 27, 2009)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on December 8, 2008)

[AmylinPharmaceuticals, Inc. letterhead] (Filed With SEC on July 31, 2008)

AMENDED AND RESTATED COMMERCIALSUPPLY AGREEMENT (Filed With SEC on July 31, 2008)

Addendum to September 19, 2002 U.S. Co-Promotion Agreement by andbetween AmylinPharmaceuticals, Inc. and Eli Lillyand Company AddendumEffective as of May 8th,2008 (Filed With SEC on July 31, 2008)

CONSULTINGAGREEMENT (Filed With SEC on July 31, 2008)

THIRD AMENDMENT TO SUPPLY AGREEMENT (Filed With SEC on July 31, 2008)

AMYLIN PHARMACEUTICALS, INC. AMENDED AND RESTATED 2001 EQUITYINCENTIVE PLAN (Filed With SEC on May 2, 2008)

SECONDAMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on March 13, 2008)

AMYLINPHARMACEUTICALS, INC. AMENDED AND RESTATED OFFICER CHANGE IN CONTROL SEVERANCE BENEFIT PLAN (Filed With SEC on August 7, 2007)

AmylinPharmaceuticals, Inc. 3.00%Convertible Senior Notes due 2014 Purchase Agreement (Filed With SEC on June 8, 2007)

AMYLIN PHARMACEUTICALS, INC. ISSUER THE BANK OF NEW YORK TRUST COMPANY, N.A. TRUSTEE INDENTURE Dated as of June 8, 2007 3.00% CONVERTIBLE SENIOR NOTES DUE 2014 (Filed With SEC on June 8, 2007)

AmylinPharmaceuticals, Inc. 3.00%Convertible Senior Notes due 2014 RegistrationRights Agreement (Filed With SEC on June 8, 2007)

EMPLOYMENTAGREEMENT (Filed With SEC on May 2, 2007)

Summary Description of NamedExecutive Officer Oral At-Will Employment Agreement (Filed With SEC on February 26, 2007)

C O N F ID E N T I A L COMMERCIALSUPPLY AGREEMENT (Filed With SEC on February 26, 2007)

C O N FI D E N T I AL (Filed With SEC on February 26, 2007)

The CORPORATEplan forRetirementSM EXECUTIVE PLAN BASICPLAN DOCUMENT IMPORTANTNOTE (Filed With SEC on February 26, 2007)

EMPLOYMENTSUCCESSION AGREEMENT (Filed With SEC on August 7, 2006)

Amylin Pharmaceuticals, Inc. Common Stock Underwriting Agreement (Filed With SEC on March 30, 2006)

AMENDMENTTO DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on March 7, 2006)

Amylin Pharmaceuticals, Inc. Common Stock Underwriting Agreement (Filed With SEC on September 1, 2005)

CommercialSupply Agreement for Pramlintide (Filed With SEC on August 8, 2005)

TheCORPORATEplan for RetirementSM EXECUTIVE PLAN AdoptionAgreement IMPORTANTNOTE (Filed With SEC on July 1, 2005)

COMMERCIAL SUPPLY AGREEMENT (Filed With SEC on March 10, 2005)

COMMERCIALSUPPLY AGREEMENT (Filed With SEC on March 10, 2005)

COMMERCIAL SUPPLYAGREEMENT (Filed With SEC on March 10, 2005)

SummaryDescription of Named Executive Officer OralAt-Will Employment Agreement (Filed With SEC on March 10, 2005)

AmylinPharmaceuticals, Inc. CommonStock UnderwritingAgreement (Filed With SEC on January 21, 2005)

AMYLINPHARMACEUTICALS, INC. To J.P.MORGAN TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee INDENTURE Datedas of April6, 2004 2.50% Convertible Senior Notes due2011 TABLE OF CONTENTS (Filed With SEC on May 10, 2004)

2 AMYLIN PHARMACEUTICALS, INC. (Filed With SEC on May 10, 2004)

Amylin Pharmaceuticals, Inc. 2.50% Convertible Senior Notes due 2011 Registration Rights Agreement (Filed With SEC on May 10, 2004)

CO N F I D E N T I A L EXENATIDEMANUFACTURING AGREEMENT (Filed With SEC on March 12, 2004)

Commercial Supply Agreement forExenatide (Filed With SEC on March 12, 2004)

SUBLEASE (Filed With SEC on March 12, 2004)

LEASE AGREEMENT (Filed With SEC on March 12, 2004)

AMYLIN PHARMACEUTICALS, INC. 2003 NON-EMPLOYEE DIRECTORS STOCK OPTION PLAN STOCK OPTION AGREEMENT (NONSTATUTORY STOCK OPTION) (Filed With SEC on November 13, 2003)

AmylinPharmaceuticals, Inc. 2001 Equity Incentive Plan StockOption Agreement (Incentive Stock Option or Nonstatutory Stock Option) (Filed With SEC on November 13, 2003)

Amylin Pharmaceuticals, Inc. 2001 Equity Incentive Plan Stock Option Agreement (Incentive Stock Option or Nonstatutory Stock Option) (Filed With SEC on November 13, 2003)

EMPLOYMENT AGREEMENT (Filed With SEC on November 13, 2003)

CO N F I D E N T I A L (Filed With SEC on November 13, 2003)

CONFIDENTIAL LIMITED MANUFACTURING AND SUPPLY AGREEMENT (Filed With SEC on November 13, 2003)

AMENDMENT NO. 1 TO AMYLIN PHARMACEUTICALS, INC. CHANGE IN CONTROL EMPLOYEE SEVERANCE BENEFIT PLAN (Filed With SEC on November 13, 2003)

AMYLIN PHARMACEUTICALS, INC. ISSUER TO J.P. MORGAN TRUST COMPANY, NATIONAL ASSOCIATION, TRUSTEE INDENTURE Dated as of June 23, 2003 2.25% CONVERTIBLE SENIOR NOTES DUE June 30,... (Filed With SEC on August 14, 2003)

2 AMYLIN PHARMACEUTICALS,INC. 2.25% CONVERTIBLE SENIORNOTE DUE JUNE 30, 2008 (Filed With SEC on August 14, 2003)

AmylinPharmaceuticals, Inc. 2.25% Convertible Senior Notes due 2008 Registration Rights Agreement (Filed With SEC on August 14, 2003)

AMYLIN PHARMACEUTICALS, INC. AND ELI LILLY AND COMPANY SECURITY AGREEMENT JUNE 30, 2003 Table of Contents (Filed With SEC on August 14, 2003)

DEVICE DEVELOPMENTAND MANUFACTURING AGREEMENT (Filed With SEC on August 14, 2003)

Amylin Pharmaceuticals, Inc. 2001 Deferred Compensation Plan Effective April 1, 2001 Amended February 19, 2003 Table OfContents (Filed With SEC on May 15, 2003)

FIRST AMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on March 31, 2003)

COVER PAGE (Filed With SEC on November 13, 2002)

Form of Underwriting Agreement by and among Amylin Pharmaceuticals, Inc., Goldman Sachs & Co. and Lehman Brothers Inc (Filed With SEC on February 12, 2002)

Category

Industry

Companies

Contracts

AMYLIN PHARMACEUTICALS INC Contracts & Agreements